Sound waves against seizures: new device tested for Drug-Resistant epilepsy

NCT ID NCT06492720

Recruiting now Disease control Sponsor: NaviFUS Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests a device called NaviFUS that uses low-intensity focused ultrasound to calm overactive brain areas. It involves 16 adults with drug-resistant epilepsy who still have frequent seizures despite trying at least three medications. The goal is to see if the treatment safely reduces seizure frequency over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: low-intensity focused ultrasound (LIFU) via NaviFUS system
What this could lead to: If it works, this could offer a non-invasive way to reduce seizures in people with epilepsy that doesn't respond to medication.
What could go wrong: This is a very small, early pilot study with only 16 people. It may not show clear benefit, and the effect on seizures could be temporary or inconsistent.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRUG-RESISTANT EPILEPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Drug Resistant Epilepsy epilepsy focal epilepsy temporal lobe epilepsy visual epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRUG-RESISTANT EPILEPSY EPILEPSY EPILEPSY, TEMPORAL LOBE SEIZURES, FOCAL

Contacts and locations

Locations

Taipei Veterans General Hospital
RECRUITING

Taipei, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.